- All sections
- C - Chemistrymetallurgy
- C07H - Sugarsderivatives thereofnucleosidesnucleotidesnucleic acids
- C07H 19/12 - Triazine radicals
Patent holdings for IPC class C07H 19/12
Total number of patents in this class: 127
10-year publication summary
8
|
15
|
6
|
12
|
6
|
9
|
7
|
10
|
3
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Celgene Corporation | 1470 |
5 |
Gilead Sciences, Inc. | 1968 |
5 |
ScinoPharm Taiwan, Ltd. | 130 |
5 |
Ohara Pharmaceutical Co., Ltd. | 36 |
5 |
Merck Sharp & Dohme LLC | 3750 |
5 |
Cilag AG | 12 |
4 |
Geron Corporation | 175 |
4 |
Emory University | 1587 |
3 |
Epigenetics Pharma LLC | 6 |
3 |
Southern Research Institute | 210 |
3 |
Janssen Biopharma, Inc. | 49 |
3 |
Centre National de La Recherche Scientifique | 10149 |
2 |
Massachusetts Institute of Technology | 9929 |
2 |
Board of Regents, The University of Texas System | 5648 |
2 |
The Johns Hopkins University | 5543 |
2 |
Jiangsu Aosaikang Pharmaceutical Co., Ltd. | 37 |
2 |
MBC Pharma, Inc. | 11 |
2 |
Modernatx, Inc. | 1204 |
2 |
Oregon Health & Science University | 759 |
2 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2846 |
2 |
Other owners | 64 |